Lene Hjerrild Iversen

Lene Hjerrild Iversen serves as a Clinical Professor at Aalborg University's Faculty of Medicine, Department of Gastrointestinal Surgery, and holds the position of Chief Physician (Ledende overlæge) at Aalborg University Hospital. Her work bridges academic research and clinical practice in gastrointestinal oncology.

Her research interests focus on colorectal cancer treatment and outcomes, with particular expertise in surgical outcomes, venous thromboembolism in cancer patients, ctDNA analysis for treatment guidance, and biomarker development for early cancer detection. Her fingerprint analysis shows strong concentration in colorectal carcinoma research (100%), with significant work in malignant neoplasms (39%), deep vein thrombosis (37%), and fibrinolysis (34%).

Her recent publications demonstrate a clear trajectory toward precision oncology, with 2025 publications focusing on ctDNA analysis for guiding adjuvant treatment and quality indicators in national clinical registries. Earlier work established her expertise in surgical outcomes related to caseload and specialization. Her research has substantial real-world impact, with multiple publications referenced in policy sources, clinical guidelines, patents, and widely covered in media.

Her work has generated significant academic attention, with one 2019 biomarker study accumulating 111 Scopus citations, 134 Mendeley readers, and policy impact. The 2022 meta-analysis on postoperative complications has 15 citations and 24 Mendeley readers. Her research demonstrates consistent impact across clinical practice, policy, and academic circles.

Dr. Iversen maintains active clinical and research collaborations, with her work referenced across multiple platforms including news outlets, policy documents, clinical guidelines, patents, and social media. Her research has been covered by 1 news outlet, referenced in 2 policy sources, posted by 9 X users, referenced in 1 patent, and shared on 1 Facebook page.